Marsh & McLennan Companies, Inc.
NYSE: MRSH · FINANCIAL SERVICES · INSURANCE BROKERS
Updated 2026-04-29
Marsh & McLennan Companies, Inc. (MRSH) Financial Forecast & Price Target 2030
Research-backed projections from analyst consensus, management guidance, and sector analysis.
Price target summary
Management guidance
Management has not provided explicit revenue targets through 2030 in available guidance. However, the company expects a 4.4% revenue increase in 2026 and is executing its 'Thrive program' for efficiency gains and market expansion. The company is strategically expanding into private markets (AltamarCAM acquisition, €20B AUM) and leveraging AI capabilities (Network Navigator healthcare technology) to drive growth.
Revenue & price projection
Financial forecast — research-backed
| Metric | 2023 | 2024 | 2025 | 2026 (E) | 2027 (E) | 2028 (E) | 2029 (E) | 2030 (E) |
|---|---|---|---|---|---|---|---|---|
| Revenue | $22.7B | $24.5B | $27.0B | $28.9B | $30.3B | $31.9B | $33.7B | $35.6B |
| Revenue growth | — | 7.6% | 10.3% | 6.9% | 5.1% | 5.4% | 5.5% | 5.6% |
| EPS | $7.98 | $8.54 | $9.48 | $10.60 | $11.56 | $12.35 | $13.18 | $14.08 |
| P/S ratio | — | — | — | 12.0x | 12.0x | 12.0x | 12.0x | 12.0x |
| Implied price | — | — | — | $698.44 | $750.82 | $785.75 | $820.67 | $873.05 |
Catalysts & risks
Methodology
Marsh & McLennan Companies, Inc.'s forward estimates are derived from AI-powered research synthesis combining analyst consensus from 9 Wall Street analysts, management guidance from the latest earnings call, and sector growth forecasts from industry research. Revenue and EPS projections use analyst consensus where available and conservative extrapolation with growth deceleration for outer years. Price targets are calculated using a tiered Price-to-Sales (P/S) methodology, where the P/S multiple is determined by the projected revenue growth rate.
WallStSmart proprietary research model · Not financial advice · Past performance is not indicative of future results · Last researched: April 6, 2026.